Efficacy and safety of endobiliary radiofrequency ablation for the eradication of residual neoplasia after endoscopic papillectomy: a multicenter prospective study

Endobiliary dysplasia may persist after endoscopic papillectomy. Intraductal radiofrequency ablation (ID-RFA) is a potential alternative to complementary surgery. The aim of this study was to evaluate the efficacy and safety of ID-RFA for the treatment of adenomatous intraductal residue after endosc...

Full description

Saved in:
Bibliographic Details
Published in:Gastrointestinal endoscopy 2018-09, Vol.88 (3), p.511-518
Main Authors: Camus, Marine, Napoléon, Bertrand, Vienne, Ariane, Le Rhun, Marc, Leblanc, Sarah, Barret, Maximilien, Chaussade, Stanislas, Robin, Françoise, Kaddour, Nadira, Prat, Frederic
Format: Article
Language:English
Subjects:
Adenocarcinoma - pathology
Adenocarcinoma - surgery
Adenoma - pathology
Adenoma - surgery
Aged
Ampulla of Vater - pathology
Ampulla of Vater - surgery
Common Bile Duct Neoplasms - pathology
Common Bile Duct Neoplasms - surgery
Female
Humans
Life Sciences
Male
Middle Aged
Neoplasm, Residual - pathology
Neoplasm, Residual - surgery
Prospective Studies
Radiofrequency Ablation
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Endobiliary dysplasia may persist after endoscopic papillectomy. Intraductal radiofrequency ablation (ID-RFA) is a potential alternative to complementary surgery. The aim of this study was to evaluate the efficacy and safety of ID-RFA for the treatment of adenomatous intraductal residue after endoscopic papillectomy. A prospective open-label multicenter study included patients with histologically proven endobiliary adenoma remnant (ductal extent 
ISSN:0016-5107
1097-6779
DOI:10.1016/j.gie.2018.04.2332